Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters Carried Out as Part of the Routine

Launched by CERBAXPERT · Nov 20, 2023

Keywords

ClinConnect Summary

This clinical trial is designed to collect extra biological samples from patients who may have COVID-19. The goal is to better understand how well different tests for the virus work, including their accuracy and reliability. This research is important because COVID-19 can affect people in many ways, from having no symptoms to being seriously ill. By monitoring the biological factors related to COVID-19, the study aims to improve the quality of the tests currently used in hospitals and clinics.

To participate in this study, you need to be at least 18 years old and coming in for a routine medical test related to COVID-19. You can be someone who is healthy, has tested positive for COVID-19, or is currently hospitalized for the virus. If you decide to join, the process will not significantly change your usual medical care, and you will need to provide informed consent, meaning you understand what the study involves. This study is not yet recruiting participants, so there will be more information available soon.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient over 18 years old
• • Patient coming for a biological analysis as part of the care for prevention, screening or monitoring of the pathogen target
• • Patient able to understand the information note and give a free and informed consent, on paper or digital media
• * Clinical patients:
• • Control cases (all comers or ambulatory)
• • Known positive for the pathology concerned
• • Patient hospitalized for the pathology concerned
• • Pregnant or breastfeeding patient
• • Dialysis patient
• Exclusion Criteria:
• • Patient already included in a research protocol
• • Patient having received medication or treatment experimental or investigational during the last four weeks before collection
• • Patient subject to a legal protection measure
• • Patient affiliated with state medical aid (AME)
• • Patient not affiliated to the compulsory Social Security system
• • Refusal or inability to provide signed informed consent
• • According to the investigator, the patient is not eligible for inclusion in the study